212 related articles for article (PubMed ID: 196039)
1. Antiviral activity in the rabbit cornea of adenine arabinoside, Ara-A 5' monophosphate, and hypoxanthine arabinoside; and interactions with adenosine deaminase inhibitor.
Falcon MG; Jones BR
J Gen Virol; 1977 Jul; 36(1):199-202. PubMed ID: 196039
[TBL] [Abstract][Full Text] [Related]
2. Antiviral activity of an adenosine deaminase inhibitor: decreased replication of herpes simplex virus.
Williams BB; Lerner AM
J Infect Dis; 1975 Jun; 131(6):673-7. PubMed ID: 166117
[TBL] [Abstract][Full Text] [Related]
3. Anti-herpes activity of adenine arabinoside monophosphate.
Trobe JD; Centifanto Y; Zam ZS; Varnell E; Kaufman HE
Invest Ophthalmol; 1976 Mar; 15(3):196-9. PubMed ID: 1254407
[TBL] [Abstract][Full Text] [Related]
4. Antiherpesvirus activity in human sera and urines after administration of adenine arabinoside: in vitro and in vivo synergy of adenine arabinoside and arabinosylhypoxanthine in combination.
Champney KJ; Lauter CB; Bailey EJ; Lerner AM
J Clin Invest; 1978 Dec; 62(6):1142-53. PubMed ID: 219024
[TBL] [Abstract][Full Text] [Related]
5. Effect of a novel adenosine deaminase inhibitor (co-vidarabine, co-V) upon the antiviral activity in vitro and in vivo of vidarabine (Vira-Atm) for DNA virus replication.
Sloan BJ; Kielty JK; Miller FA
Ann N Y Acad Sci; 1977 Mar; 284():60-80. PubMed ID: 212990
[TBL] [Abstract][Full Text] [Related]
6. Ara AMP- a highly soluble new antiviral drug.
Pavan-Langston D; North RD; Geary PA
Ann Ophthalmol; 1976 May; 8(5):571-9. PubMed ID: 937940
[TBL] [Abstract][Full Text] [Related]
7. Antiviral activity of arabinosyladenine and arabinosylhypoxanthine in herpes simplex virus-infected KB cells: selective inhibition of viral deoxyribonucleic acid synthesis in the presence of an adenosine deaminase inhibitor.
Schwartz PM; Shipman C; Drach JC
Antimicrob Agents Chemother; 1976 Jul; 10(1):64-74. PubMed ID: 185947
[TBL] [Abstract][Full Text] [Related]
8. Effect of 9-beta-D-arabinofuranosyladenine 5'-monophosphate and 9-beta-D-arabinofuranosylhypoxanthine 5'-monophosphate on experimental herpes simplex keratitis.
Kaufman HE; Varnell ED
Antimicrob Agents Chemother; 1976 Dec; 10(6):885-8. PubMed ID: 1008546
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the antiviral effects of 5-methoxymethyldeoxyuridine-5'-monophosphate with adenine arabinoside-5'-monophosphate.
Ayisi NK; Meldrum JB; Stuart AL; Gupta VS
Antiviral Res; 1983 Sep; 3(3):161-74. PubMed ID: 6197027
[TBL] [Abstract][Full Text] [Related]
10. Herpes simplex keratitis: animal models to guide the selection and optimal delivery of antiviral chemotherapy.
Falcon MG; Jones BR
J Antimicrob Chemother; 1977 Mar; 3 Suppl A():83-9. PubMed ID: 863807
[No Abstract] [Full Text] [Related]
11. Anti-herpesvirus activity of adenine arabinoside analogues in tissue culture and a genital infection of mice and guinea pigs.
Richards JT; Kern ER; Overall JC; Glasgow LA
Antiviral Res; 1982 May; 2(1-2):27-39. PubMed ID: 6179469
[TBL] [Abstract][Full Text] [Related]
12. Viral keratitis-inhibitory effect of 9-beta-D-arabinofuranosylhypoxanthine 5'-monophosphate.
Sidwell RW; Allen LB; Huffman JH; Revankar GR; Robins RK; Tolman RL
Antimicrob Agents Chemother; 1975 Oct; 8(4):463-7. PubMed ID: 1190753
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy of herpetic keratitis induced by acyclovir-resistant strains of herpes simplex virus type 1.
O'Brien WJ; Taylor JL
Am J Med; 1982 Jul; 73(1A):294-9. PubMed ID: 6285720
[TBL] [Abstract][Full Text] [Related]
14. Latent herpes simplex virus infections in sensory ganglia of mice after topical treatment with adenine arabinoside and adenine arabinoside monophosphate.
Klein RJ; Friedman-Kien AE
Antimicrob Agents Chemother; 1977 Nov; 12(5):577-81. PubMed ID: 200172
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory and lethal concentrations of 9-beta-D-arabinofuranosyladenine and its hypoxanthine-derivative versus herpes simplex virus, type 1.
Williams BB; Bailey EJ; Lerner AM
J Lab Clin Med; 1977 Apr; 89(4):687-91. PubMed ID: 191546
[TBL] [Abstract][Full Text] [Related]
16. Erythro-9-(2-hydroxy-3-nonyl) Adenine alone and in combination with 9-beta-D-arabinofuranosyladenine in treatment of systemic herpesvirus infections in mice.
Shannon WM; Arnett G; Schabel FM; North TW; Cohen SS
Antimicrob Agents Chemother; 1980 Oct; 18(4):598-603. PubMed ID: 6255863
[TBL] [Abstract][Full Text] [Related]
17. Metabolism and pharmacokinetics of the anti-varicella-zoster virus agent 6-dimethylaminopurine arabinoside.
Lambe CU; Resetar A; Spector T; Koszalka GW; Nelson DJ
Antimicrob Agents Chemother; 1992 Feb; 36(2):353-60. PubMed ID: 1318679
[TBL] [Abstract][Full Text] [Related]
18. Erythro-9-(2-hydroxy-3-nonyl)adenine as a specific inhibitor of herpes simplex virus replication in the presence and absence of adenosine analogues.
North TW; Cohen SS
Proc Natl Acad Sci U S A; 1978 Oct; 75(10):4684-8. PubMed ID: 216993
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of adenosine deaminase by co-vidarabine and its effect on the metabolic disposition of adenine arabinoside (vidarabine).
Borondy PE; Chang T; Maschewske E; Glazko AJ
Ann N Y Acad Sci; 1977 Mar; 284():9-20. PubMed ID: 280160
[No Abstract] [Full Text] [Related]
20. Adenine arabinoside inhibition of adenovirus replication enhanced by an adenosine deaminase inhibitor.
Wigand R
J Med Virol; 1979; 4(1):59-65. PubMed ID: 119038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
